Aptamer Sciences, Inc.
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Public
- Established
- 2011-04-01
- Employees
- 39
- Market Cap
- -
- Website
- http://www.aptsci.com
A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients with GPC3-positive Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- NeoplasmsCarcinoma, HepatocellularCarcinoma, Non-Small-Cell LungLiver Neoplasms
- Interventions
- First Posted Date
- 2024-11-14
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Aptamer Sciences, Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT06687941
- Locations
- π°π·
National Cancer Center, Korea, Gyeonggi, Korea, Republic of
π°π·CHA Bundang Medical Center, Seongnam, Korea, Republic of
π°π·Severance Hospital, Seoul, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath